Global Naloxone Hydrochloride Injection Market Research Report 2024

Publication ID:

PB506245992

Publication Date:

June 25, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Naloxone Hydrochloride Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Naloxone Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Naloxone Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Naloxone Hydrochloride Injection include Shanxi PUDE Pharmaceutical, Chengdu Easton Bio Pharmaceuticals., HeBei Aoxing Group Pharmaceutical, Kangzhe (Hunan) Pharmaceutical, Beijing Sihuan Pharmaceutical, Hainan Bikai Pharmaceutical, Chengdu Tiantai Mountain Pharmaceutical, Shandong Xinhua Pharmaceutical and Xi'an Disai Biopharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Naloxone Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naloxone Hydrochloride Injection.
Report Scope
The Naloxone Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Naloxone Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naloxone Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanxi PUDE Pharmaceutical
Chengdu Easton Bio Pharmaceuticals.
HeBei Aoxing Group Pharmaceutical
Kangzhe (Hunan) Pharmaceutical
Beijing Sihuan Pharmaceutical
Hainan Bikai Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
Shandong Xinhua Pharmaceutical
Xi'an Disai Biopharmaceutical
AuroMedics Pharma
Narcan
Somerset Therapeutics
Flagship Biotech International
Livealth
Segment by Type
1ml/Unit
2ml/Unit
10ml/Unit
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naloxone Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naloxone Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Naloxone Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Naloxone Hydrochloride Injection
1.2 Naloxone Hydrochloride Injection Segment by Type
1.2.1 Global Naloxone Hydrochloride Injection Market Value Comparison by Type (2024-2030)
1.2.2 1ml/Unit
1.2.3 2ml/Unit
1.2.4 10ml/Unit
1.3 Naloxone Hydrochloride Injection Segment by Application
1.3.1 Global Naloxone Hydrochloride Injection Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Naloxone Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Naloxone Hydrochloride Injection Revenue 2019-2030
1.4.2 Global Naloxone Hydrochloride Injection Sales 2019-2030
1.4.3 Global Naloxone Hydrochloride Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Naloxone Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Naloxone Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Naloxone Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Naloxone Hydrochloride Injection Average Price by Manufacturers (2019-2024)
2.4 Global Naloxone Hydrochloride Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Naloxone Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naloxone Hydrochloride Injection, Product Type & Application
2.7 Naloxone Hydrochloride Injection Market Competitive Situation and Trends
2.7.1 Naloxone Hydrochloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Naloxone Hydrochloride Injection Players Market Share by Revenue
2.7.3 Global Naloxone Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Naloxone Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Naloxone Hydrochloride Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Naloxone Hydrochloride Injection Global Naloxone Hydrochloride Injection Sales by Region: 2019-2030
3.2.1 Global Naloxone Hydrochloride Injection Sales by Region: 2019-2024
3.2.2 Global Naloxone Hydrochloride Injection Sales by Region: 2025-2030
3.3 Global Naloxone Hydrochloride Injection Global Naloxone Hydrochloride Injection Revenue by Region: 2019-2030
3.3.1 Global Naloxone Hydrochloride Injection Revenue by Region: 2019-2024
3.3.2 Global Naloxone Hydrochloride Injection Revenue by Region: 2025-2030
3.4 North America Naloxone Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Naloxone Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Naloxone Hydrochloride Injection Sales by Country (2019-2030)
3.4.3 North America Naloxone Hydrochloride Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Naloxone Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Naloxone Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Naloxone Hydrochloride Injection Sales by Country (2019-2030)
3.5.3 Europe Naloxone Hydrochloride Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naloxone Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Naloxone Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Naloxone Hydrochloride Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Naloxone Hydrochloride Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Naloxone Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Naloxone Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Naloxone Hydrochloride Injection Sales by Country (2019-2030)
3.7.3 Latin America Naloxone Hydrochloride Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Naloxone Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Naloxone Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Naloxone Hydrochloride Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Naloxone Hydrochloride Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naloxone Hydrochloride Injection Sales by Type (2019-2030)
4.1.1 Global Naloxone Hydrochloride Injection Sales by Type (2019-2024)
4.1.2 Global Naloxone Hydrochloride Injection Sales by Type (2025-2030)
4.1.3 Global Naloxone Hydrochloride Injection Sales Market Share by Type (2019-2030)
4.2 Global Naloxone Hydrochloride Injection Revenue by Type (2019-2030)
4.2.1 Global Naloxone Hydrochloride Injection Revenue by Type (2019-2024)
4.2.2 Global Naloxone Hydrochloride Injection Revenue by Type (2025-2030)
4.2.3 Global Naloxone Hydrochloride Injection Revenue Market Share by Type (2019-2030)
4.3 Global Naloxone Hydrochloride Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Naloxone Hydrochloride Injection Sales by Application (2019-2030)
5.1.1 Global Naloxone Hydrochloride Injection Sales by Application (2019-2024)
5.1.2 Global Naloxone Hydrochloride Injection Sales by Application (2025-2030)
5.1.3 Global Naloxone Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Naloxone Hydrochloride Injection Revenue by Application (2019-2030)
5.2.1 Global Naloxone Hydrochloride Injection Revenue by Application (2019-2024)
5.2.2 Global Naloxone Hydrochloride Injection Revenue by Application (2025-2030)
5.2.3 Global Naloxone Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Naloxone Hydrochloride Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Shanxi PUDE Pharmaceutical
6.1.1 Shanxi PUDE Pharmaceutical Corporation Information
6.1.2 Shanxi PUDE Pharmaceutical Description and Business Overview
6.1.3 Shanxi PUDE Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Shanxi PUDE Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.1.5 Shanxi PUDE Pharmaceutical Recent Developments/Updates
6.2 Chengdu Easton Bio Pharmaceuticals.
6.2.1 Chengdu Easton Bio Pharmaceuticals. Corporation Information
6.2.2 Chengdu Easton Bio Pharmaceuticals. Description and Business Overview
6.2.3 Chengdu Easton Bio Pharmaceuticals. Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chengdu Easton Bio Pharmaceuticals. Naloxone Hydrochloride Injection Product Portfolio
6.2.5 Chengdu Easton Bio Pharmaceuticals. Recent Developments/Updates
6.3 HeBei Aoxing Group Pharmaceutical
6.3.1 HeBei Aoxing Group Pharmaceutical Corporation Information
6.3.2 HeBei Aoxing Group Pharmaceutical Description and Business Overview
6.3.3 HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HeBei Aoxing Group Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.3.5 HeBei Aoxing Group Pharmaceutical Recent Developments/Updates
6.4 Kangzhe (Hunan) Pharmaceutical
6.4.1 Kangzhe (Hunan) Pharmaceutical Corporation Information
6.4.2 Kangzhe (Hunan) Pharmaceutical Description and Business Overview
6.4.3 Kangzhe (Hunan) Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kangzhe (Hunan) Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.4.5 Kangzhe (Hunan) Pharmaceutical Recent Developments/Updates
6.5 Beijing Sihuan Pharmaceutical
6.5.1 Beijing Sihuan Pharmaceutical Corporation Information
6.5.2 Beijing Sihuan Pharmaceutical Description and Business Overview
6.5.3 Beijing Sihuan Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Beijing Sihuan Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.5.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
6.6 Hainan Bikai Pharmaceutical
6.6.1 Hainan Bikai Pharmaceutical Corporation Information
6.6.2 Hainan Bikai Pharmaceutical Description and Business Overview
6.6.3 Hainan Bikai Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hainan Bikai Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.6.5 Hainan Bikai Pharmaceutical Recent Developments/Updates
6.7 Chengdu Tiantai Mountain Pharmaceutical
6.6.1 Chengdu Tiantai Mountain Pharmaceutical Corporation Information
6.6.2 Chengdu Tiantai Mountain Pharmaceutical Description and Business Overview
6.6.3 Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Tiantai Mountain Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.7.5 Chengdu Tiantai Mountain Pharmaceutical Recent Developments/Updates
6.8 Shandong Xinhua Pharmaceutical
6.8.1 Shandong Xinhua Pharmaceutical Corporation Information
6.8.2 Shandong Xinhua Pharmaceutical Description and Business Overview
6.8.3 Shandong Xinhua Pharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shandong Xinhua Pharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.8.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
6.9 Xi'an Disai Biopharmaceutical
6.9.1 Xi'an Disai Biopharmaceutical Corporation Information
6.9.2 Xi'an Disai Biopharmaceutical Description and Business Overview
6.9.3 Xi'an Disai Biopharmaceutical Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Xi'an Disai Biopharmaceutical Naloxone Hydrochloride Injection Product Portfolio
6.9.5 Xi'an Disai Biopharmaceutical Recent Developments/Updates
6.10 AuroMedics Pharma
6.10.1 AuroMedics Pharma Corporation Information
6.10.2 AuroMedics Pharma Description and Business Overview
6.10.3 AuroMedics Pharma Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AuroMedics Pharma Naloxone Hydrochloride Injection Product Portfolio
6.10.5 AuroMedics Pharma Recent Developments/Updates
6.11 Narcan
6.11.1 Narcan Corporation Information
6.11.2 Narcan Naloxone Hydrochloride Injection Description and Business Overview
6.11.3 Narcan Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Narcan Naloxone Hydrochloride Injection Product Portfolio
6.11.5 Narcan Recent Developments/Updates
6.12 Somerset Therapeutics
6.12.1 Somerset Therapeutics Corporation Information
6.12.2 Somerset Therapeutics Naloxone Hydrochloride Injection Description and Business Overview
6.12.3 Somerset Therapeutics Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Somerset Therapeutics Naloxone Hydrochloride Injection Product Portfolio
6.12.5 Somerset Therapeutics Recent Developments/Updates
6.13 Flagship Biotech International
6.13.1 Flagship Biotech International Corporation Information
6.13.2 Flagship Biotech International Naloxone Hydrochloride Injection Description and Business Overview
6.13.3 Flagship Biotech International Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Flagship Biotech International Naloxone Hydrochloride Injection Product Portfolio
6.13.5 Flagship Biotech International Recent Developments/Updates
6.14 Livealth
6.14.1 Livealth Corporation Information
6.14.2 Livealth Naloxone Hydrochloride Injection Description and Business Overview
6.14.3 Livealth Naloxone Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Livealth Naloxone Hydrochloride Injection Product Portfolio
6.14.5 Livealth Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naloxone Hydrochloride Injection Industry Chain Analysis
7.2 Naloxone Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naloxone Hydrochloride Injection Production Mode & Process
7.4 Naloxone Hydrochloride Injection Sales and Marketing
7.4.1 Naloxone Hydrochloride Injection Sales Channels
7.4.2 Naloxone Hydrochloride Injection Distributors
7.5 Naloxone Hydrochloride Injection Customers
8 Naloxone Hydrochloride Injection Market Dynamics
8.1 Naloxone Hydrochloride Injection Industry Trends
8.2 Naloxone Hydrochloride Injection Market Drivers
8.3 Naloxone Hydrochloride Injection Market Challenges
8.4 Naloxone Hydrochloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Shanxi PUDE Pharmaceutical
Chengdu Easton Bio Pharmaceuticals.
HeBei Aoxing Group Pharmaceutical
Kangzhe (Hunan) Pharmaceutical
Beijing Sihuan Pharmaceutical
Hainan Bikai Pharmaceutical
Chengdu Tiantai Mountain Pharmaceutical
Shandong Xinhua Pharmaceutical
Xi'an Disai Biopharmaceutical
AuroMedics Pharma
Narcan
Somerset Therapeutics
Flagship Biotech International
Livealth

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂